Product Information

CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0197 per EA under NDC 72888015200. Its NADAC has been published 173 times since Jul 26, 2023.

FDA first approved this application on Oct 6, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLONAZEPAM 0.5 MG TABLET

Clonazepam
$0.0197per EA
DEA Schedule CIV

Strength

.5 mg/1

NDC

72888015200

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA075468

FDA Approved

10/6/2000

TE Code

AB

On Market Since

4/14/2022

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 173 times since Jul 26, 2023, and over the history we have for it it has declined 27.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0197 per EA
All-time high$0.0284 (Oct 16, 2024)
All-time low$0.0174 (Nov 20, 2024)
52-week high$0.0223
52-week low$0.0196
Median price$0.0218
Average price$0.0225
Largest weekly change-34.1% (Nov 20, 2024)
Weeks tracked173
Tracking sinceJul 26, 2023

Price History

1W

0.0%

1M

+0.3%

3M

-0.3%

6M

-1.8%

1Y

-10.9%

3Y

-25.0%

5Y

N/A

All

-27.2%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0197 per EA (NDC 72888015200), effective Nov 11, 2026.

How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has declined 27.2%. It has been tracked across 173 weekly CMS publications since Jul 26, 2023.

What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?

Since Jul 26, 2023, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0284 (Oct 16, 2024), with a median of $0.0218 per EA.

Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLONAZEPAM 0.5 MG TABLET?

CLONAZEPAM 0.5 MG TABLET (NDC 72888015200) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.